Literature DB >> 25417033

Post-cardiac Arrest Syndrome in Children.

Dominique Biarent, Christine Fonteyne, Ariane Willems, Audrey Dupont1.   

Abstract

Although sustained return of spontaneous circulation (ROSC) can be initially established after resuscitation in children, many of the children do not survive to discharge because they developped a post cardiac arrest syndrome. The post-cardiac arrest syndrome includes systemic ischaemia/reperfusion response, post-cardiac arrest brain injury, postcardiac arrest myocardial dysfunction, and persistent precipitating pathology. The main cause of death after ROSC in children is brain injury. Physiopathology and management are reviewed in regards of pediatric specificities. Management according to ABCDE includes airway and ventilation management, oxygen therapy, hemodynamic management with early goal directed therapy and protection of the brain against secondary injury by therapeutic hypothermia, management of seizures and control of glycemia.

Entities:  

Year:  2013        PMID: 25417033     DOI: 10.2174/1573396311309020005

Source DB:  PubMed          Journal:  Curr Pediatr Rev        ISSN: 1573-3963


  3 in total

1.  Demographics of Pediatric OHCA Survivors With Postdischarge Diseases: A National Population-Based Follow-Up Study.

Authors:  Tsung-Han Lee; I-Cheng Juan; Hsiu-Ying Hsu; Wen-Liang Chen; Cheng-Chieh Huang; Mei-Chueh Yang; Wei-Yuan Lei; Chih-Ming Lin; Chu-Chung Chou; Chin-Fu Chang; Yan-Ren Lin
Journal:  Front Pediatr       Date:  2020-01-24       Impact factor: 3.418

2.  Early coagulopathy after pediatric out-of-hospital cardiac arrest: secondary analysis of a randomized clinical trial.

Authors:  Dawei Zhou; Tong Li; Yi Lv; Dijia Wang; Rongli Zhang; Qing Lin; Chao Wang; Dong Zhao; Shuyang Fei; Wei He
Journal:  Thromb J       Date:  2022-10-11

3.  Invasion of Peripheral Immune Cells into Brain Parenchyma after Cardiac Arrest and Resuscitation.

Authors:  Can Zhang; Nicole R Brandon; Kerryann Koper; Pei Tang; Yan Xu; Huanyu Dou
Journal:  Aging Dis       Date:  2018-06-01       Impact factor: 6.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.